| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |